You are here: Industry Insights > Telix

News List

Telix Completes Acquisition of Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform PRNewswire
January 31, 2025
Telix completes the acquisition from ImaginAb, getting a drug pipeline and a biologics technology platform.
Telix to Acquire Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform PR Newswire
January 13, 2025
Telix Pharma acquires ImaginAb's therapeutic pipeline, tech platform & research facility for innovation boost
Telix Files TLX250-CDx (Zircaix®) BLA for Kidney Cancer Imaging PRNewswire
December 30, 2024
Telix is a biopharmaceutical company focused on the development and commercialisation of diagnostic and therapeutic radiopharmaceuticals and associated medical technologies.
SHINE and Telix Pharmaceuticals Enter Clinical Supply Agreement contractpharma
February 11, 2022
SHINE to supply n.c.a. Lu-177 for the clinical development of Telix’s investigational radiopharmaceuticals, TLX591 and TLX250.
Ryoichi Tanaka Joins Telix Japan as COO firstwordpharma
August 06, 2021
Telix Pharmaceuticals Limited (ASX: TLX, 'Telix', the 'Company') is pleased to announce that Mr. Ryoichi Tanaka has joined the Telix Japan leadership team in the role of Chief Operating Officer and Head of Business Development.
Helen Hovenga Joins Telix as Chief People Officer firstwordpharma
August 04, 2021
Telix Pharmaceuticals Limited (ASX: TLX, 'Telix', the 'Company') is pleased to announce that Ms. Helen Hovenga has joined the Telix executive team in the role of Chief People Officer (CPO).
Kyahn Williamson Joins Telix to Lead Corporate Communications and Investor Relations firstwordpharma
July 12, 2021
Telix Pharmaceuticals Limited (ASX: TLX, 'Telix', the 'Company') is pleased to announce that Ms. Kyahn Williamson has joined the Telix executive leadership team in the role of Senior Vice President of Corporate Communications and Investor Relations.
Telix Pharmaceuticals acquires Swiss-German biotechnology company TheraPharm pharmaceutical-business-review
December 01, 2020
Telix Pharmaceuticals announces it has entered into an agreement with Scintec Diagnostics to acquire TheraPharm GmbH, a Swiss-German biotechnology company developing innovative diagnostic and therapeutic solutions in the field of hematology.
Telix, Eczacıbaşı-Monrol Sign Manufacturing Agreement contractpharma
June 21, 2019
Working together for six months on tech transfer of radiopharmaceutical manufacturing methods for TLX250-CDx.
Telix to Acquire ANMI for €5.15M contractpharma
November 27, 2018
Telix Pharmaceuticals Limited has announced the acquisition of Advanced Nuclear Medicine Ingredients (ANMI) SA for €5.15m in cash and shares.